NCT01470274

Safety of the CO-rebreathing Method in Stable Coronary Artery Disease and COPD Patients

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 18 (actual)
• Sponsor: Norwegian University of Science and Technology · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The primary objective is to establish the safety of the CO-rebreathing method for measuring total blood and plasma volume in CAD patients. The working hypothesis is that the CO-rebreathing method is safe in use with coronary artery disease patients and that it does not cause myocardial ischemia or cardiovascular damage.

Conditions

• Cardiovascular Disease
• Chronic Obstructive Pulmonary Disease

Timeline

• Start date: 2011-11-01
• Primary completion: 2012-01-01
• Completion: 2012-02-01
• First posted: 2011-11-11
• Last updated: 2016-07-29

Locations

1 site across 1 country: Norway